119 results
F-1/A
EX-10.6
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
by way of a penalty in respect of your personalnon-compliance with any requirement of a regulatory nature howsoever arising;
any amount for which … of a penalty in respect ofnon-compliance with any requirement of a regulatory nature howsoever arising, and
any amount for which you have become
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligations to determine whether … . In determining the appropriate method for measuring progress, we consider the nature of the service that we promise to transfer to the customer. When we
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm
to use, and benefit from, the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined … include output methods and input methods. In determining the appropriate method for measuring progress, we consider the nature of service that we promise
6-K
EX-99.1
AUTL
Autolus Therapeutics plc
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
response (CR) experienced any NT and all cases of NT reported have been atypical in nature and seen in a setting with disease progression and confounding
6-K
AUTL
Autolus Therapeutics plc
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
on FormF-3 (FileNo. 333-232690).
Forward-Looking Statements
Statements in this Report that are not strictly historical in nature, including statements
6-K
EX-99.3
znsn6 3xn
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
0nwg5
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
8-K
EX-10.1
4a50jq usqri5
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
6-K
EX-99.2
nobach2v0u5o
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
n1xy1i lm2s2s
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
2ymzg8fpvtv px
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K/A
EX-99.2
q22o9ei
21 Nov 22
Current report (foreign) (amended)
4:03pm
8-K
ffnbvldwo13r43dxa0hl
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
6-K
EX-99.2
5osmvmm39v3h3d5w3k
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
m5131 p4jy61ryyo7
3 Nov 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.2
nfwisofrsf9d3p
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
6-K
EX-99.2
ca1hxijoqk1opedyxph
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.1
aaz6y329y9v4 fi4o77h
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.2
92a e6vt07
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-99.1
gzvufun1l vcj2s
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm